“As it relates to medicine, we believe our treatments can be converted to tablets. This would represent a large cost savings to us as we scale, but for the purposes of our medical research, it makes no sense to explore this now – our scientific staff is working at capacity,” added Mr. Hoffman. “In clinical situations, we envision the future of our technology utilizes computer automated. An MRI-like machine will scan the patient for localized bioinformation anomalies, compute a waveform correction treatment, and broadcast the treatment directly into the patient.”